Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Peters

Showing results (21-30 of 92) with videos related to

Pageof 10
Sort By:
International Journal of Radiation Oncology, Biology, Physics|February 3, 2020
Patient-Reported Outcomes of Oligometastatic Patients After Conventional or Stereotactic Radiation Therapy to Bone Metastases: An Analysis of the PRESENT CohortSaskia van de Ven, Desiree van den Bongard, Bart Pielkenrood, et al.
Journal of Contemporary Brachytherapy|January 25, 2017
Comparative cost-effectiveness of focal and total salvage <sup>125</sup>I brachytherapy for recurrent prostate cancer after primary radiotherapyMax Peters, Marjanne A Piena, Lotte M G Steuten, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 27, 2022
[Experiences with MRI-guided brachytherapy for radiorecurrent prostate cancer]Marnix J A Rasing, Max Peters, M A Moerland, et al.
Acta Oncologica (Stockholm, Sweden)|July 29, 2021
Progression-free survival in patients with <sup>68</sup>Ga-PSMA-PET-directed SBRT for lymph node oligometastasesAnita M Werensteijn-Honingh, Anne F J Wevers, Max Peters, et al.
International Journal of Radiation Oncology, Biology, Physics|January 4, 2025
Defining the Optimal Radiation-induced Lymphopenia Metric to Discern Its Survival Impact in Esophageal CancerPim J J Damen, Max Peters, Brian Hobbs, et al.
BJU International|March 5, 2017
Focal salvage high-intensity focused ultrasound in radiorecurrent prostate cancerAbi Kanthabalan, Max Peters, Marco Van Vulpen, et al.
Urologic Oncology|March 14, 2025
Predicting pathological tumor volume in prostate cancer lesions: A head-to-head comparison of micro-ultrasound vs. MRIAdrien Richemond, Max Peters, Sandy Schaer, et al.
Clinical and Translational Radiation Oncology|June 7, 2022
The impact of para-aortic lymph node irradiation on disease-free survival in patients with cervical cancer: A systematic review and meta-analysisLeslie J H Bukkems, Ina M Jürgenliemk-Schulz, Femke van der Leij, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 10, 2015
Urethral and bladder dosimetry of total and focal salvage Iodine-125 prostate brachytherapy: Late toxicity and dose constraintsMax Peters, Jochem van der Voort van Zyp, Carel Hoekstra, et al.
Gynecologic Oncology|December 31, 2021
Upstaging by para-aortic lymph node dissection in patients with locally advanced cervical cancer: A systematic review and meta-analysisAnnelou A B Thelissen, Ina M Jürgenliemk-Schulz, Femke van der Leij, et al.
Pageof 10

Showing results (21-30 of 92) with videos related to

Sort By:
Pageof 10
International Journal of Radiation Oncology, Biology, Physics|February 3, 2020
Patient-Reported Outcomes of Oligometastatic Patients After Conventional or Stereotactic Radiation Therapy to Bone Metastases: An Analysis of the PRESENT CohortSaskia van de Ven, Desiree van den Bongard, Bart Pielkenrood, et al.
Journal of Contemporary Brachytherapy|January 25, 2017
Comparative cost-effectiveness of focal and total salvage <sup>125</sup>I brachytherapy for recurrent prostate cancer after primary radiotherapyMax Peters, Marjanne A Piena, Lotte M G Steuten, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 27, 2022
[Experiences with MRI-guided brachytherapy for radiorecurrent prostate cancer]Marnix J A Rasing, Max Peters, M A Moerland, et al.
Acta Oncologica (Stockholm, Sweden)|July 29, 2021
Progression-free survival in patients with <sup>68</sup>Ga-PSMA-PET-directed SBRT for lymph node oligometastasesAnita M Werensteijn-Honingh, Anne F J Wevers, Max Peters, et al.
International Journal of Radiation Oncology, Biology, Physics|January 4, 2025
Defining the Optimal Radiation-induced Lymphopenia Metric to Discern Its Survival Impact in Esophageal CancerPim J J Damen, Max Peters, Brian Hobbs, et al.
BJU International|March 5, 2017
Focal salvage high-intensity focused ultrasound in radiorecurrent prostate cancerAbi Kanthabalan, Max Peters, Marco Van Vulpen, et al.
Urologic Oncology|March 14, 2025
Predicting pathological tumor volume in prostate cancer lesions: A head-to-head comparison of micro-ultrasound vs. MRIAdrien Richemond, Max Peters, Sandy Schaer, et al.
Clinical and Translational Radiation Oncology|June 7, 2022
The impact of para-aortic lymph node irradiation on disease-free survival in patients with cervical cancer: A systematic review and meta-analysisLeslie J H Bukkems, Ina M Jürgenliemk-Schulz, Femke van der Leij, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 10, 2015
Urethral and bladder dosimetry of total and focal salvage Iodine-125 prostate brachytherapy: Late toxicity and dose constraintsMax Peters, Jochem van der Voort van Zyp, Carel Hoekstra, et al.
Gynecologic Oncology|December 31, 2021
Upstaging by para-aortic lymph node dissection in patients with locally advanced cervical cancer: A systematic review and meta-analysisAnnelou A B Thelissen, Ina M Jürgenliemk-Schulz, Femke van der Leij, et al.
Pageof 10